NIELSEN, NATHAN DEAN
NIELSEN, NATHAN DEAN
Dipartimento Chirurgico,Medico,Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa
Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock
2026 Coloretti, I.; Tosi, M.; Biagioni, E.; Morselli, F.; Munari, E.; Bertolini, J.; Ferrari, S.; Meschiari, M.; Franceschini, E.; Nielsen, N. D.; Busani, S.; Girardis, M.
Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review
2024 Coloretti, I.; Genovese, A.; Teixeira, J. P.; Cherian, A.; Ferrer, R.; Landoni, G.; Leone, M.; Girardis, M.; Nielsen, N. D.
Knowledge gaps in extracorporeal blood purification: what would be required for its successful application in septic shock?
2025 David, S.; Rimmele, T.; Joannidis, M.; Girardis, M.; Pickkers, P.; Nielsen, N. D.; Buhlmann, A.; Molnar, Z.; Ostermann, M.; Kielstein, J. T.; Wendel-Garcia, P. D.; Bode, C.; Stahl, K.
Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis
2024 Girardis, M.; David, S.; Ferrer, R.; Helms, J.; Juffermans, N. P.; Martin-Loeches, I.; Povoa, P.; Russell, L.; Shankar-Hari, M.; Iba, T.; Coloretti, I.; Parchim, N.; Nielsen, N. D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock | 1-gen-2026 | Coloretti, I.; Tosi, M.; Biagioni, E.; Morselli, F.; Munari, E.; Bertolini, J.; Ferrari, S.; Meschiari, M.; Franceschini, E.; Nielsen, N. D.; Busani, S.; Girardis, M. | |
| Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review | 1-gen-2024 | Coloretti, I.; Genovese, A.; Teixeira, J. P.; Cherian, A.; Ferrer, R.; Landoni, G.; Leone, M.; Girardis, M.; Nielsen, N. D. | |
| Knowledge gaps in extracorporeal blood purification: what would be required for its successful application in septic shock? | 1-gen-2025 | David, S.; Rimmele, T.; Joannidis, M.; Girardis, M.; Pickkers, P.; Nielsen, N. D.; Buhlmann, A.; Molnar, Z.; Ostermann, M.; Kielstein, J. T.; Wendel-Garcia, P. D.; Bode, C.; Stahl, K. | |
| Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis | 1-gen-2024 | Girardis, M.; David, S.; Ferrer, R.; Helms, J.; Juffermans, N. P.; Martin-Loeches, I.; Povoa, P.; Russell, L.; Shankar-Hari, M.; Iba, T.; Coloretti, I.; Parchim, N.; Nielsen, N. D. |